Teagasc Food Research Centre, Moorepark, Fermoy, Co Cork, Ireland.
J Antimicrob Chemother. 2013 Jan;68(1):214-21. doi: 10.1093/jac/dks348. Epub 2012 Sep 4.
The human intestinal microbiota composition alters naturally with age, but is unusually perturbed by antibiotic therapy. The impact of antibiotic therapy on the composition of the intestinal microbiota of a cross-section of elderly Irish subjects (n = 185, ≥ 65 years) was investigated, taking into consideration their residence location.
Forty-two of the 185 elderly subjects were treated with at least one antibiotic within 1 month prior to faecal microbiota profiling. The residence locations of the subjects varied from long-term nursing care and rehabilitation wards to day hospitals and the community.
Culture-dependent methods indicated that faecal Bifidobacterium spp. numbers were significantly reduced following antibiotic treatment (P = 0.004, 7-fold reduction), while levels of Lactobacillus spp. and Enterobacteriaceae were unaffected. The largest decrease in Bifidobacterium spp. numbers was linked to the administration of nucleic acid synthesis inhibitors (P = 0.004, 23-fold reduction). Microbiota profiling revealed a significant compositional change across nine genera following antibiotic therapy, including a relative increase in Lactobacillus spp. (P = 0.031), as well as a decrease in the number of genera identified in the antibiotic-treated subjects (n = 58), when compared with untreated subjects (n = 79). More alterations in the intestinal microbiota were observed post-nucleic acid synthesis inhibitor therapy, most notably a decrease in relative Faecalibacterium spp. numbers (P < 0.001).
The impact of antibiotic therapy on the intestinal microbiota in the elderly should be considered for long-term health effects, and differential susceptibility may require the development of products (e.g. prebiotics and probiotics) for at-risk subjects.
人类肠道微生物组成会随着年龄的自然变化而变化,但抗生素治疗会异常扰乱肠道微生物组。本研究调查了抗生素治疗对爱尔兰老年人(≥65 岁,n=185)肠道微生物群组成的影响,并考虑了他们的居住地点。
185 名老年人中有 42 人在粪便微生物群特征分析前 1 个月内至少接受了一种抗生素治疗。这些老年人的居住地点从长期护理和康复病房到日间医院和社区不等。
培养依赖的方法表明,粪便双歧杆菌数量在抗生素治疗后显著减少(P=0.004,减少了 7 倍),而乳酸杆菌和肠杆菌科的数量不受影响。双歧杆菌数量的最大减少与核酸合成抑制剂的给药有关(P=0.004,减少了 23 倍)。微生物组分析显示,抗生素治疗后有 9 个属的组成发生了显著变化,包括乳酸杆菌属相对增加(P=0.031),以及治疗组中鉴定的属数量减少(n=58),与未治疗组(n=79)相比。在核酸合成抑制剂治疗后,肠道微生物群发生了更多的变化,最显著的是粪便真杆菌属数量相对减少(P<0.001)。
应考虑抗生素治疗对老年人肠道微生物群的长期健康影响,并且可能需要为高危人群开发产品(例如,益生菌)以获得差异化的疗效。